BioNeuronics Raises Series B

BioNeuronics Corp. (f.k.a. NeuroVista), a Seattle-based developer of a neurostimulation device to manage and treat epilepsy, has raised $33.8 million in Series B funding. Advanced Technology Ventures and Delphi Ventures co-led the deal, and were joined by return backers Three Arch Partners, Sprout Group and Foundation Medical Partners. The company previously had raised $9.3 million in a tranched-out deal that held a first close in late 2004.